Dark
Light
System
Institutional Investment Manager
RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. (CIK: 0001346824) incorporated in Delaware, located at 200 Berkeley Street, 18th Floor, Boston, MA. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q1)
Portfolio Summary: 57 holdings with a total value of $988,380,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 SANGAMO BIOSCIENCES INCORPORATED 6,000,000 94,080,000 9.52% Call
2 ACHILLION PHARMACEUTICALS INC COM 8,207,530 80,926,000 8.19%
3 DYAX CORP COM CVR 4,207,594 70,498,000 7.13%
4 BIOCRYST PHARMACEUTICALS 6,926,617 62,547,000 6.33%
5 REGULUS THERAPEUTICS INC 3,590,688 60,826,000 6.15%
6 Dicerna Pharmaceuticals 2,428,571 58,359,000 5.90%
7 DYNAVAX TECHNOLOGIES CORP 2,600,000 58,318,000 5.90%
8 TG THERAPEUTICS INC COM 3,125,149 48,377,000 4.89%
9 COHERUS BIOSCIENCES INC COM 1,555,355 47,563,000 4.81%
10 Tekmira Pharmaceuticals Corp. 2,714,800 47,400,000 4.80%
11 XENCOR INC COM 2,149,423 32,929,000 3.33%
12 ZAFGEN INC COM 732,960 29,033,000 2.94%
13 BLUEBIRD BIO INCORPORATED 200,379 24,200,000 2.45%
14 ZS PHARMA INC 564,483 23,753,000 2.40%
15 SANGAMO BIOSCIENCES INCORPORATED 1,220,209 19,133,000 1.94%
16 Ascendis Pharma 1,023,652 17,760,000 1.80%
17 JUNO THERAPEUTICS INCORPORATED 280,000 16,985,000 1.72%
18 OMEROS CORP 749,000 16,500,000 1.67%
19 Proteon Therapeutics 1,250,000 14,538,000 1.47%
20 Agile Therapeutics, Inc. 1,458,792 13,523,000 1.37%
21 NOVAVAX INC COM 1,431,232 11,836,000 1.20%
22 THERAPEUTICSMD INC 1,680,395 10,166,000 1.03%
23 ARRAY BIOPHARMA INC COM 1,357,584 10,005,000 1.01%
24 CONCERT PHARMACEUTICALS INC COM 660,000 9,996,000 1.01%
25 Orexigen Therapeutics, Inc. 1,186,229 9,288,000 0.94%
26 TENAX THERAPEUTICS INC COM 2,670,300 8,705,000 0.88%
27 TREVENA INC 1,325,407 8,642,000 0.87%
28 SUCAMPO PHARMACEUTICALS INC 450,000 7,002,000 0.71%
29 AKEBIA THERAPEUTICS INC 597,363 6,637,000 0.67%
30 Vical Inc 7,024,274 6,637,000 0.67%
31 AURINIA PHARMACEUTICALS INC 1,504,776 6,561,000 0.66%
32 SCYNEXIS INC 789,097 6,550,000 0.66%
33 BELLICUM PHARMACEUTICALS INC COM 225,000 5,213,000 0.53%
34 AURIS MED HLDG AG 940,000 5,029,000 0.51%
35 VERSARTIS INC COM 231,267 4,248,000 0.43%
36 TROVAGENE INC COM NEW 594,200 4,047,000 0.41%
37 BIOTA PHARMACEUTIALS INC COM 1,403,853 3,229,000 0.33%
38 ROCKWELL MED INC COM 250,207 2,735,000 0.28%
39 T2 BIOSYSTEMS INC 138,002 2,142,000 0.22%
40 OCERA THERAPEUTICS INC 417,476 1,966,000 0.20%
41 ONCOTHYREON INC COM N/C EFF 6/ 1,165,765 1,900,000 0.19%
42 AGIOS PHARMACEUTICALS INC 17,600 1,660,000 0.17%
43 NEWLINK GENETICS CORP 30,000 1,641,000 0.17%
44 PTC THERAPEUTICS INC 25,800 1,570,000 0.16%
45 SANOFI SPOND FUNSPONSORED ADR 116,400 1,383,000 0.14%
46 REPLIGEN CORP COM 45,000 1,366,000 0.14%
47 TESARO INC 23,500 1,349,000 0.14%
48 ALKERMES PLC SHS 19,200 1,171,000 0.12%
49 WAFERGEN BIO-SYSTEMS INC 255,400 1,157,000 0.12%
50 REGENERON PHARMACEUTICALS 2,450 1,106,000 0.11%
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-031600, filed 2015.05.15).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.